CoChat

Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background Ketamine has proven to have rapid, robust antidepressant effects on treatment-resistant depression. However, whether repeated ketamine infusions would cause short-and long-term neurocognitive impairments was not clear. Our aims were to investigate the neurocognitive effects of six ketamine infusions and to examine the association between these infusions and the antidepressant response in patients with unipolar and bipolar depression. Methods Six intravenous infusions of ketamine (0.5 mg/kg) over a 12-day period were administered to 84 patients with unipolar and bipolar depression. Severity of depressive symptoms and four domains of neurocognition, including speed of processing, working memory, visual learning and verbal learning, were assessed at baseline, one day following the last infusion and again two weeks post-infusion. Results Significant improvements were found on speed of processing ( F=9.344, p Conclusions Our findings suggest that neurocognitive function would not deteriorate after six ketamine infusions, while verbal learning and speed of processing improved over 13 days and 26 days of observation, respectively. However, this change was mainly accounted for by improvements in severity of depressive symptoms over time. Greater baseline visual learning predicted an antidepressant response over six ketamine infusions.

Overview

Integrity signals

Registry

Crossref · 10.1177/0269881118798614

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 38 references

Research works printed but not linked: 1

  1. Colle R, 2016, World J Biol Psychiatry, 1

Cited by

See all 76

Metadata

Authors
Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., Chen, L., Li, M., & Ning, Y.
Affiliations
  • Guangzhou Medical University (CN)
  • State Key Laboratory of Diagnosis and Treatment of Infectious Diseases (CN)
Corresponding author
Ning, Yuping
Venue
Journal of Psychopharmacology
Published
2018-09-27
Volume
32
Issue
10
Pages
1118-1126
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2893295941
Cited by
73
References
38
Citations by year
2026: 6 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 12 · 2021: 12 · 2020: 14 · 2019: 3 · 2018: 1
FWCI
4.84
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Key Research and Development Program of China (2016YFC0906300)
  • Science and Technology Department of Guangdong Province major science and technology (2016B010108003)
  • Planed Science and Technology Projects of Guangzhou (201607010131)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
ketamine, neurocognitive effects, antidepressant response, major depressive disorder, bipolar depression, processing speed, verbal learning, visual learning, working memory, depressive symptoms, treatment-resistant depression
MeSH terms
Adult, Antidepressive Agents, Bipolar Disorder, Cognition, Major Depressive Disorder, Female, Follow-Up Studies, Humans, Infusions, Intravenous, Ketamine, Male, Memory, Short-Term, Middle Aged, Neuropsychological Tests, Severity of Illness Index, Time Factors, Verbal Learning, Young Adult, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. https://app.cochat.ai/papers/10.1177/0269881118798614
The paper
Zhou, Y., Zheng, W., Liu, W., Wang, C., Zhan, Y., Li, H., Chen, L., Li, M., & Ning, Y. (2018). Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. Journal of Psychopharmacology. https://doi.org/10.1177/0269881118798614

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.